ClinicaliQ Trial Snapshot
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight — Active Not Recruiting • Phase III • Diabetes / Metabolic • NCT05726227.
- Semaglutide weekly injections help children and teenagers lose weight better than placebo, alongside lifestyle support.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This study will look at how well semaglutide helps children and teenagers losing weight. This will be tested by comparing the effect on body weight in children and teenagers taking semaglutide in comparison to placebo, a "dummy" medicine. In addition to taking the medicine, the child's parent and the child will have talks with study staff about healthy food choices, how to be more physically active and what your child can do to try to lose weight. The child will either get semaglutide or a "dummy" medicine. Which treatment the…